Skip Navigation LinksHome > July 2014 - Volume 36 - Issue 7 > Striking Follicular Eruption to Pegylated Liposomal Doxorubi...
American Journal of Dermatopathology:
doi: 10.1097/DAD.0000000000000077
Brief Report

Striking Follicular Eruption to Pegylated Liposomal Doxorubicin

Dai, Julia BS; Micheletti, Robert MD; Rosenbach, Misha MD; Chu, Emily Y. MD, PhD

Collapse Box

Abstract

The adverse effects of pegylated liposomal doxorubicin are primarily cutaneous. The majority of these cutaneous side effects manifest as palmar–plantar erythrodysesthesia, whereas few reports of other cutaneous reactions exist in the literature. The authors report a case of an exuberant follicular eruption in a patient treated with pegylated liposomal doxorubicin. This case also highlights the potential mechanism underlying this unusual histological and clinical reaction.

© 2014 Lippincott Williams & Wilkins

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.